MacroGenics | MGNX - Ativos

Preço das Ações
3.60
Mudança Diária
0.16 4.65%
Mensal
7.78%
Anual
179.07%
Q2 Previsão
3.50




Ativos Alterar Data
AbbVie USD 133.96B 62M 2025-12
Amgen USD 90.59B 445M 2025-12
AstraZeneca USD 114.07B 382M 2025-12
Biogen USD 29.44B 232M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Daiichi Sankyo JPY 3.82T 252.52B 2025-12
Eli Lilly USD 112.48B 2.46B 2025-12
Genmab DKK 12.87B 5.85B 2025-12
Geron USD 570.54M 3.16M 2025-12
Gilead Sciences USD 59.02B 490M 2025-12
J&J USD 199.21B 6.39B 2025-12
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
MacroGenics USD 256.85M 13.92M 2025-12
Merck USD 129.55B 12.02B 2025-09
Pfizer USD 208.73B 2.64B 2025-09
Puma Biotechnology USD 202.86M 7.95M 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Xencor USD 875.5M 6.68M 2025-12